References
- Ahn SH, Son BH, Kim SW, et al (2007). Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. J Clin Oncol, 25, 2360-8. https://doi.org/10.1200/JCO.2006.10.3754
- Bauer KR, Brown M, Cress RD, et al (2007). Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8. https://doi.org/10.1002/cncr.22618
- Cancello G, Maisonneuve P, Rotmensz N, et al (2010). Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol, 21, 1974-81. https://doi.org/10.1093/annonc/mdq072
- Chung M, Chang HR, Bland KI, et al (1996).Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103. https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
- Colleoni M, Rotmensz N, Robertson C, et al (2002) . Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
- FitzGerald MG, MacDonald DJ, Krainer M, et al (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med, 334, 143-9. https://doi.org/10.1056/NEJM199601183340302
- Gajdos C, Tartter PI, Bleiweiss IJ, et al (2000). Stage 0 to stage _ breast cancer in young women. J Am Coll Surg, 190, 523-9. https://doi.org/10.1016/S1072-7515(00)00257-X
- Goldhirsch A, Glick JH, Gelber RD, et al (1998). Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst, 90, 1601-8. https://doi.org/10.1093/jnci/90.21.1601
- Goldhirsch A, Glick JH, Gelber RD, et al (2001). Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol, 19, 3817-27.
- Han W, Kim SW, Park IA, et al (2004).Young age: An independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer, 17, 82.
- Kim JK, Kwak BS, Lee JS, et al (2007). Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol, 14, 3385-91. https://doi.org/10.1245/s10434-006-9345-9
- Kim JK, Kwak BS, Lee JS, et al (2007). Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol, 14, 3385-91. https://doi.org/10.1245/s10434-006-9345-9
- Kothari AS, Beechey-Newman N, D Arrigo C, et al (2002). Breast carcinoma in women age 25 years or less. Cancer, 94, 606-14. https://doi.org/10.1002/cncr.10273
- Madaras L, Baranyak Z, Kulka J, et al (2013). Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of hungarian patients. Pathol Oncol Res, 19, 723-9. https://doi.org/10.1007/s12253-013-9635-z
- Meng J, Lang RG, Fan Y, Fu L (2007). [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]. Zhonghua Zhong Liu Za Zhi, 29, 284-8. [Article in Chinese]
- Muscolino G, Villani C, Bedini AV, et al (1987). Young age is not an ominous prognostic factor in breast cancer patients. Tumori, 73, 233-5.
- Osborne CK, Shou J, Massarweh S, et al (2005). Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res, 11, 865-70.
- Robson M, Gilewski T, Haas B, et al (1998). BRCA-associated breast cancer in young women. J Clin Oncol, 16, 1642-9.
- Schmidt RT, Tsangaris TN, Cheek JH (1991). Breast cancer in women under 35 years of age. Am J Surg, 162, 197-201. https://doi.org/10.1016/0002-9610(91)90068-O
- Vrieling C, Collette L, Fourquet A, et al (2003). Can patient-treatment-and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer, 39, 932-44. https://doi.org/10.1016/S0959-8049(03)00123-0
- Winchester DP(1996).Breast cancer in young women. Surg Clin North Am, 76, 279-87. https://doi.org/10.1016/S0039-6109(05)70439-4
Cited by
- Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35) vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6665
- Distinct Postsurgical Management in Young and Elderly Breast Cancer Patients Results in Equal Survival Rates vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7843
- Prognosis of Breast Cancer Patients Underwent Surgery in a Developing Country vol.06, pp.09, 2015, https://doi.org/10.4236/jct.2015.69088
- Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-1207-z
- Breast Cancer at Extreme Ages - a Comparative Analysis in Chile vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1455
- Young Women with Breast Cancer in the United States and South Korea: Comparison of Demographics, Pathology and Management vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2531
- Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0165409
- Clinicopathological features and survival of early stage breast cancer in northwest China: A population-based retrospective study of 1287 patients pp.17597706, 2017, https://doi.org/10.1111/1759-7714.12503
- TNM stage at diagnosis is more predictive of prognosis than pathological complete response in young breast cancer treated with neoadjuvant chemotherapy pp.0959-4973, 2017, https://doi.org/10.1097/CAD.0000000000000577